- Cal-Maine’s second-quarter earnings per share (EPS) were $4.47, significantly beating last year’s EPS of $0.35 and the estimated EPS of $4.05.
- The company reported net sales of $954.7 million, marking an 82% increase compared to the previous year and exceeding the estimated $751.5 million.
- Cal-Maine sold 329.84 million dozen eggs, which is a 14% increase from the previous year.
- The net average selling price per dozen eggs rose by 58% year-over-year, reaching $2.740.
- Analyst ratings include 1 buy recommendation and 1 hold, with no sell ratings.
“`
A look at Cal Maine Foods Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 5 | |
| Resilience | 4 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 4.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Cal-Maine Foods, Inc. is poised for a promising long-term outlook based on the Smartkarma Smart Scores evaluation. With a high score of 5 in Growth and Momentum, the company shows strong potential for future expansion and market performance. The Value score of 3 indicates a fair valuation of the company’s assets, while the Dividend and Resilience scores of 4 reflect solid returns and stability. Cal-Maine Foods’ focus on producing, cleaning, grading, packing, and selling fresh shell eggs positions it well within various states in the Southwestern, Southeastern, Midwestern, and Mid-Atlantic regions of the United States.
Overall, the Smartkarma Smart Scores suggest that Cal-Maine Foods is set to thrive in the long run, supported by robust growth prospects and positive market momentum. The company’s strategic positioning in key regions coupled with its strong dividend yield and resilience bode well for its future performance. Investors may find Cal-Maine Foods an attractive opportunity with its balanced portfolio across different regions and a focus on delivering quality fresh shell eggs to the market.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
